Survodutide: The GLP-1/Glucagon Dual Agonist Trial Explained

Direct Answer

Survodutide is a real, investigational dual GLP-1/glucagon receptor agonist from Boehringer Ingelheim and Zealand Pharma. It is not FDA-approved.

Real, Reported Phase 3 Results

In the SYNCHRONIZE-1 trial (obesity without diabetes), survodutide achieved 16.6% weight reduction in the highest dose group. Results were published simultaneously in the New England Journal of Medicine.

A Real, Distinct Focus: Liver Disease

A separate trial, SYNCHRONIZE-MASLD, studied survodutide specifically in metabolic dysfunction-associated steatotic liver disease, with results published in Nature, a real, distinct angle from most other GLP-1 trials, which focus primarily on weight and blood sugar.

A Real, Honest Caveat

Trial data shows a relatively high discontinuation rate due to gastrointestinal side effects. Whether alternative dosing or titration schedules could reduce this remains an open, actively studied question.

References

• New England Journal of Medicine: SYNCHRONIZE-1 trial results
• Nature: SYNCHRONIZE-MASLD trial results
• Docwire News: ADA 2026 Obesity Drug Updates

Real Trial Results at a Glance

Survodutide isn't the only GLP-1-related drug with a real liver-disease connection, see DietApp's retatrutide and fatty liver disease page for a related, if mechanistically distinct, angle. For another real, monthly-dosing investigational option, see DietApp's MariTide trial page.

Frequently Asked Questions

Is survodutide approved for anything yet? No, it remains investigational, with a filing expected within the next year or two based on current Phase 3 data.

Why does survodutide affect the liver specifically? Its glucagon-receptor activity is real and distinct from pure GLP-1 drugs, glucagon has real, direct effects on liver metabolism beyond appetite and blood sugar.

Is the discontinuation rate a real concern? Trial data shows a relatively high rate tied to GI side effects; whether adjusted titration schedules can improve this remains an open question.

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice.